Immune checkpoint inhibitor rechallenge in patients with immune-related myositis

Ann Rheum Dis. 2019 Nov;78(11):e129. doi: 10.1136/annrheumdis-2018-214336. Epub 2018 Sep 21.

Julie Delyon^{1

2

3}, Florence Brunet-Possenti^{3

4}, Sarah Leonard-Louis^{5

6}, Dimitri Arangalage^{3

7

8}, Mathilde Baudet⁹, Barouyr Baroudjian¹⁰, Celeste Lebbe^{10

2

3}, Baptiste Hervier^{6

11

12}; PATIO Group

¹ Department of Dermatology, APHP Saint Louis Hospital, Paris, France julie.delyon@aphp.fr.
² INSERM U976, Paris, France.
³ Paris Diderot, Sorbonne Paris Cité University, Paris, France.
⁴ Department of Dermatology, APHP Bichat Hospital; Paris VII Diderot, Sorbonne Paris Cité University, Paris, France.
⁵ Department of Neurology and Neuropathology, APHP Pitié-Salpêtrière Hospital, Paris, France.
⁶ UPMC, Médecine Sorbonne Université, Paris, France.
⁷ Cardiology Department, APHP Bichat Hospital, Paris, France.
⁸ INSERM U1148, Paris, France.
⁹ Department of Cardiology, APHP Saint Louis Hospital, Paris, France.
¹⁰ Department of Dermatology, APHP Saint Louis Hospital, Paris, France.
¹¹ Department of Internal Medicine, APHP Pitié-Salpêtrière Hospital, Paris, France.
¹² INSERM U1135-CIMI, Paris, France.

No abstract available

Keywords: autoimmunity; polymyositis; treatment.

Publication types